Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Evaluation of the Probability of Non-sentinel Lymph Node Metastasis in Breast Cancer Patients with Sentinel Lymph Node Metastasis using Two Different Methods.

Başoğlu İ, Çelik MF, Dural AC, Ünsal MG, Akarsu C, Baytekin HF, Kapan S, Alış H.

J Breast Health (2013). 2015 Oct 1;11(4):172-179. doi: 10.5152/tjbh.2015.2686. eCollection 2015 Oct.

2.

The predictive value of methylene blue dye as a single technique in breast cancer sentinel node biopsy: a study from Dharmais Cancer Hospital.

Brahma B, Putri RI, Karsono R, Andinata B, Gautama W, Sari L, Haryono SJ.

World J Surg Oncol. 2017 Feb 7;15(1):41. doi: 10.1186/s12957-017-1113-8.

3.

Sentinel Lymph Nodes for Breast Carcinoma: A Paradigm Shift.

Maguire A, Brogi E.

Arch Pathol Lab Med. 2016 Aug;140(8):791-8. doi: 10.5858/arpa.2015-0140-RA. Review.

4.

Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.

Mamtani A, Patil S, Van Zee KJ, Cody HS 3rd, Pilewskie M, Barrio AV, Heerdt AS, Morrow M.

Ann Surg Oncol. 2016 Oct;23(11):3481-6. doi: 10.1245/s10434-016-5259-3. Epub 2016 May 11.

PMID:
27169771
5.

CK19 mRNA in blood can predict non-sentinel lymph node metastasis in breast cancer.

Yu XF, Yang HJ, Lei L, Wang C, Huang J.

Oncotarget. 2016 May 24;7(21):30504-10. doi: 10.18632/oncotarget.8851.

6.

Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population.

Padmanabhan N, Ayub MF, Hussain K, Kurien A, Radhakrishna S.

Indian J Surg Oncol. 2015 Dec;6(4):337-45. doi: 10.1007/s13193-015-0431-y. Epub 2015 Dec 5.

7.

The Extent of Axillary Surgery Is Associated With Breast Cancer-specific Survival in T1-2 Breast Cancer Patients With 1 or 2 Positive Lymph Nodes: A SEER-Population Study.

Li S, Liu F, Chen K, Rao N, Xie Y, Su F, Zhu L.

Medicine (Baltimore). 2016 Apr;95(14):e3254. doi: 10.1097/MD.0000000000003254.

8.

A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients.

Zheng Z, Zhang Y, Zhang L, Li Z, Wu X, Liu Y, Bu Z, Ji J.

BMC Cancer. 2016 Feb 12;16:92. doi: 10.1186/s12885-016-2132-5.

9.

Sentinel lymph nodes for breast carcinoma: an update on current practice.

Maguire A, Brogi E.

Histopathology. 2016 Jan;68(1):152-67. doi: 10.1111/his.12853. Review.

10.

Intradermal microbubbles and contrast-enhanced ultrasound (CEUS) is a feasible approach for sentinel lymph node identification in early-stage breast cancer.

Xie F, Zhang D, Cheng L, Yu L, Yang L, Tong F, Liu H, Wang S, Wang S.

World J Surg Oncol. 2015 Nov 19;13:319. doi: 10.1186/s12957-015-0736-x.

11.

Comparison of five different popular scoring systems to predict nonsentinel lymph node status in patients with metastatic sentinel lymph nodes: a tertiary care center experience.

Yıldız R, Urkan M, Hancerliogulları O, Kılbaş Z, Ozturk E, Mentes MO, Gorgulu S.

Springerplus. 2015 Oct 29;4:651. doi: 10.1186/s40064-015-1442-4. eCollection 2015.

12.

Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method.

Di Filippo F, Giannarelli D, Bouteille C, Bernet L, Cano R, Cunnick G, Sapino A.

J Exp Clin Cancer Res. 2015 Nov 4;34:136. doi: 10.1186/s13046-015-0246-2.

13.

Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer.

Kim JY, Park HS, Kim S, Ryu J, Park S, Kim SI.

Medicine (Baltimore). 2015 Oct;94(43):e1720. doi: 10.1097/MD.0000000000001720.

14.

Validation of Six Nomograms for Predicting Non-sentinel Lymph Node Metastases in a Dutch Breast Cancer Population.

Dingemans SA, de Rooij PD, van der Vuurst de Vries RM, Budel LM, Contant CM, van der Pool AE.

Ann Surg Oncol. 2016 Feb;23(2):477-81. doi: 10.1245/s10434-015-4858-8. Epub 2015 Sep 14.

15.

Sentinel lymph node biopsy in breast cancer.

Alsaif AA.

Saudi Med J. 2015 Sep;36(9):1053-60. doi: 10.15537/smj.2015.9.12228.

16.

Molecular biomarkers screened by next-generation RNA sequencing for non-sentinel lymph node status prediction in breast cancer patients with metastatic sentinel lymph nodes.

Liang F, Qu H, Lin Q, Yang Y, Ruan X, Zhang B, Liu Y, Yu C, Zhang H, Fang X, Hao X.

World J Surg Oncol. 2015 Aug 28;13:258. doi: 10.1186/s12957-015-0642-2.

17.

Predictive Factors for Non-Sentinel Lymph Node Metastasis in the Case of Positive Sentinel Lymph Node Metastasis in Two or Fewer Nodes in Breast Cancer.

Toshikawa C, Koyama Y, Nagahashi M, Tatsuda K, Moro K, Tsuchida J, Hasegawa M, Niwano T, Manba N, Ikarashi M, Kameyama H, Kobayashi T, Kosugi S, Wakai T.

J Clin Med Res. 2015 Aug;7(8):620-6. doi: 10.14740/jocmr2195w. Epub 2015 Jun 9.

18.

Nomograms in oncology: more than meets the eye.

Balachandran VP, Gonen M, Smith JJ, DeMatteo RP.

Lancet Oncol. 2015 Apr;16(4):e173-80. doi: 10.1016/S1470-2045(14)71116-7. Review.

19.

Prognostic value of the lymph node ratio for lymph-node-positive breast cancer- is it just a denominator problem?

Jayasinghe UW, Pathmanathan N, Elder E, Boyages J.

Springerplus. 2015 Mar 11;4:121. doi: 10.1186/s40064-015-0865-2. eCollection 2015.

20.

Validation of the Memorial Sloan Kettering Cancer Center nomogram for predicting non-sentinel lymph node metastasis in sentinel lymph node-positive breast-cancer patients.

Bi X, Wang Y, Li M, Chen P, Zhou Z, Liu Y, Zhao T, Zhang Z, Wang C, Sun X, Qiu P.

Onco Targets Ther. 2015 Feb 23;8:487-93. doi: 10.2147/OTT.S78903. eCollection 2015.

Supplemental Content

Support Center